跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bricanyl® - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bricanyl®
Approved
STANDARD
Bricanyl®
AstraZeneca Pharm'l Co., Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
43e5c1b60099f826
Company
AstraZeneca Pharm'l Co., Limited
Type
Standard
Approval Details
Approval Id
43e5c1b60099f826
Drug Approval Philippines Name
Bricanyl®
Product Name
Bricanyl®
Registration Number
DR-XY39882
Brand Name
Bricanyl®
Generic Name
Terbutaline Sulfate
Dosage Form
Tablet
Dosage Strength
2.5mg
Manufacturer
AstraZeneca Pharm'l Co., Limited
Importer
AstraZeneca Pharmaceuticals (Phils.), Inc.
Distributor
AstraZeneca Pharmaceuticals (Phils.), Inc.
Issuance Date
26 March 2021
Expiry Date
11 August 2026
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
43e5c1b60099f826
Type
Standard
Back to Philippines FDA Approvals